Does mass drug administration for scabies result in control of serious bacterial complications? A proof of concept towards global elimination. [ 2017 - 2019 ]

Research Grant

Researchers: Prof Andrew Steer (Principal investigator) ,  Dr Handan Wand ,  Dr Joseph Kado ,  Dr Lucia Romani ,  Dr Margot Whitfeld
View all 6 related researchers

Brief description Scabies is common skin disease in developing countries, in particular in the Pacific region. In Fiji, one in two children suffer from the infestation, which affects over 20% of the population. A recent study conducted in Fiji on 2000 people showed that mass drug administration (MDA) with oral ivermectin is a safe and effective way to reduce the burden of scabies in the community. We will expand the MDA program to 100,000 people, the largest study of MDA ivermectin for scabies ever undertaken.

Funding Amount $AUD 905,892.36

Funding Scheme Project Grants

Notes Standard Project Grant